Vasopressin 2 Units/2 mL in 0 — Class II drug recall D-0325-2024
Ongoing recall by IntegraDose Compounding Services LLC, reported 2024-02-21, distributed in MN. Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
| Recall number | D-0325-2024 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | IntegraDose Compounding Services LLC, Minneapolis, MN, United States |
| Recall initiated | 2024-01-22 |
| Classified | 2024-02-15 |
| Reported by FDA | 2024-02-21 |
| Distributed | MN |
| Quantity | 1,299 syringes |
| Reason classes | labeling, potency |
| NDC | 71139-0190-01 |
| Lot numbers | 20230929VAS-2, 20231004VAS-2, 20231010VAS-2, 20231013VAS-2 |
| Expiration dates | 2024-02-29, 2024-04-01, 2024-04-07, 2024-04-10 |
Product
Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.
Reason for recall
Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0325-2024. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.